Analysts and estimates

The following financial analysts monitor the market environment and the performance of Aurubis AG and make investment recommendations in accordance with their analyses and reports on Aurubis shares. The following list is not necessarily exhaustive.

Buy (overweight/outperform/add): The price of the analyzed share is expected to rise over the next 12 months.

Hold (equal-weight/neutral): The price of the analyzed share is expected to remain mostly flat over the next 12 months. 

Sell (underweight/underperform/reduce): The price of the analyzed share is expected to fall over the next 12 months.

Company Analyst Recommendation Target price in €
Deutsche Bank  Bastian Synagowitz Hold 95
Exane BNP Paribas Alan Spence Hold 77
Morgan Stanley Ioannis Masvoulas Hold 78
Oddo BHF Maxime Kogge Hold 86
Baader Bank Christian Obst  Buy 110
DZ Bank AG Dirk Schlamp Buy 85
Hauck & Aufhäuser Simon Jouck Buy 107
LBBW Jens Münstermann Buy 80
M.M. Warburg Stefan Augustin Buy 95
Metzler Thomas Schulte-Vorwick Buy 95
UBS Europe Daniel Major Buy 100
Bank of America Jason Fairclough Sell 61
Kepler Cheuvreux Rochus Brauneiser Sell 70

Data as of December 6, 2023

Legal disclaimer

Note: The analyst estimates presented are not based on research conducted by Aurubis AG, but on the assessments, reports, recommendations, and analyses of the listed equity research analysts. The presentation of this information as a service for our shareholders does not mean that Aurubis AG adopts, supports, or confirms the analysts' recommendations. None of the data and information provided on this website constitutes an offer to buy, sell, or otherwise trade in securities. In particular, the information does not contain any recommendation for an investment strategy. Aurubis AG accepts no liability whatsoever for the selection, completeness, or correctness of the analysts' assessments presented here. Aurubis AG accepts no liability for damages incurred by third parties as a result of information on this website.